Befejeződött1. fázis
A Phase 1, Dose Finding Study of CC-92328 in Subjects with Relapsed and/or Refractory Multiple Myeloma.
Key facts
- Where
- Badalona, Pamplona, Salamanca és Santander, SpanyolországSee the 4 sites
- Phase
- 1. fázis
Where in Spanyolország
- Institut Catala d'OncologiaBadalona, SpanyolországNo longer taking part
- Clínica Universidad de navarraPamplona, SpanyolországNo longer taking part
- Hospital Universitario De SalamancaSalamanca, SpanyolországNo longer taking part
- Hospital Universitario Marqués de ValdecillaSantander, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Celgene Corp.
- Trial code
- EU 2023-505079-65-00
- Record updated
- 2024. július 2.